Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Krebs, Matthew G Sloane, Robert Priest, Lynsey Lancashire, Lee J Hou, Jian-Mei Greystoke, Alastair Ward, Timothy H Ferraldeschi, Roberta Hughes, Andrew Clack, Glen
Krebs, Matthew G
Sloane, Robert
Priest, Lynsey
Lancashire, Lee J
Hou, Jian-Mei
Greystoke, Alastair
Ward, Timothy H
Ferraldeschi, Roberta
Hughes, Andrew
Clack, Glen
Citations
Altmetric:
Abstract
Lung cancer is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC) lacks validated biomarkers to predict treatment response. This study investigated whether circulating tumor cells (CTCs) are detectable in patients with NSCLC and what their ability might be to provide prognostic information and/or early indication of patient response to conventional therapy.
Description
Date
2011-04-20
Publisher
Keywords
Type
Article
Citation
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. 2011, 29 (12):1556-63 J Clin Oncol